DarcyV.SpicerMD
Oncology • Los Angeles, CAChief, Division of Medical Oncology, Keck School of Medicine of USC
Dr. Spicer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Ste 8302E
Los Angeles, CA 90089Phone+1 323-865-3105Fax+1 323-865-3868
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 1979 - 1980
McGill University, Montreal General HospitalResidencies, Internal Medicine and Hematology/Oncology, 1976 - 1979- University of Western Ontario, University HospitalInternship, 1975 - 1976
University of Calgary Faculty of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1979 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer Start of enrollment: 1997 Apr 01
- Why do Oral Contraceptives Prevent Ovarian Cancer? Start of enrollment: 2014 Jun 01
- Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials Start of enrollment: 2019 Apr 08
Publications & Presentations
PubMed
- 2 citationsEvaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.Robert Hsu, Batul Al-Zubeidy, Daniel Flores, Ari Nazarian, Aaron Baugh
Breast Cancer Research and Treatment. 2024-07-01 - 1 citationsExperiences of a Multiethnic Cohort of Patients Enrolled in a Financial Reimbursement Program for Cancer Clinical Trials.Sheyla P Medina, Sylvia Zhang, Elena Nieves, Dana L Dornsife, Robert Johnson
JCO Oncology Practice. 2023-05-01 - 12 citationsBreast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.Priya Jayachandran, Francesca Battaglin, Carly Strelez, Annika Lenz, Sandra Algaze
Oncogene. 2023-02-01
Press Mentions
On Father’s Day and Every Day, Celebrating the Fathers I’ve Known in My LifeJune 19th, 2021- Clinical Trial Explores the Use of Traditional Chinese Medicine Against COVID-19March 8th, 2021
USC Researchers Offer Financial Aid to Increase Participation in Clinical TrialsMay 31st, 2019- Join now to see all
Grant Support
- Sccisars 2: An E-Solution To Protect Human SubjectsNational Center For Research Resources2003
- Core--Clinical Investigations Support FacilityNational Cancer Institute2001–2002
- Phase II Randomized Study Of Paclitaxel VS Paclitaxel+Psc833 For Breast CancerNational Center For Research Resources1998–2002
- A Phase I Study Of The Garft Inhibitor Ag2034 In Patients With Advanced CancerNational Center For Research Resources1998–2002
- GNRH Agonist Regimen For Breast Cancer PreventionNational Cancer Institute1998
Committees
- Member, Scientific Conduct Committee, Keck School of Medicine, University of Southern California 1992 - Present
- Member, Research Review Subcommittee, Institutional Review Board, Keck School of Medicine, University of Southern California Health Sciences Campus 1988 - Present
- Member, Professional Staff Review Committee, USC Norris Cancer Hospital 1983 - Present
- Member, Pharmacy and Therapeutics Committee, USC Norris Cancer Hospital 1983 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
